To evaluate the efficacy of a novel sodium-glucose cotransporter-2 (SGLT2) inhibitor in preventing cardiovascular mortality, a multicenter, double-blind trial enrolls patients with chronic heart failure. Participants are randomly assigned to receive either the SGLT2 inhibitor or a placebo. After a median follow-up of three years, the data are analyzed. Among the patients in the intervention group, experienced a cardiovascular mortality event. In the control group, which also consisted of patients, experienced a cardiovascular mortality event. Based on these findings, what is the number needed to treat to prevent one cardiovascular mortality event over the study period?
Cevap: 25 patients
Cevap
25 patients
The Number Needed to Treat (NNT) represents the number of patients who must receive a particular intervention in order to prevent one additional adverse outcome. It is calculated as (Absolute Risk Reduction). In this study, the control event rate (CER) is , and the experimental event rate (EER) is . The ARR is . The inverse of () yields an NNT of . Therefore, patients need to be treated with the SGLT2 inhibitor to prevent one cardiovascular mortality event.
Adım Adım Çözüm
Anahtar Kavram
Number Needed to Treat (NNT) is calculated as the inverse of the Absolute Risk Reduction (ARR).